Vicarious Surgical RBOT
OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Income from Continuing Operations came in at -$11.1 million in Q3 2025, up 35.3% year-over-year from -$8.2 million in Q3 2024, and up 16.32% quarter-over-quarter from -$13.2 million in Q2 2025.

Analysis

Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Income from Continuing Operations for 6 consecutive years, with -$11.1 million the latest figure, recorded in Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 35.3% year-over-year to -$11.1 million in Q3 2025; TTM through Sep 2025 was -$53.6 million, a 14.12% increase from a year earlier, with the FY2024 full-year figure at -$63.2 million, up 11.04% from the prior year.
  • Income from Continuing Operations was -$11.1 million for Q3 2025 at Vicarious Surgical, up from -$13.2 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at $42.5 million in Q1 2022 and troughed at -$45.1 million in Q3 2021.
  • A 5-year average of -$10.7 million and a median of -$13.9 million in 2024 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations sank 24757.7% in 2021 and soared 912.98% in 2022, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at $21.8 million in 2021, then slumped by 151.32% to -$11.2 million in 2022, then retreated by 17.27% to -$13.1 million in 2023, then decreased by 6.22% to -$13.9 million in 2024, then grew by 20.59% to -$11.1 million in 2025.
  • The last three Income from Continuing Operations figures came in at -$11.1 million (Q3 2025), -$13.2 million (Q2 2025), and -$15.4 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 Vicarious Surgical 231,626.35 -14.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -11.06 Mn
Jun 30, 2025 -13.22 Mn
Mar 31, 2025 -15.39 Mn
Dec 31, 2024 -13.93 Mn
Sep 30, 2024 -17.09 Mn
Jun 30, 2024 -15.21 Mn
Mar 31, 2024 -17.00 Mn
Dec 31, 2023 -13.11 Mn
Sep 30, 2023 -15.70 Mn
Jun 30, 2023 -15.33 Mn
Mar 31, 2023 -26.92 Mn
Dec 31, 2022 -11.18 Mn
Sep 30, 2022 -24.74 Mn
Jun 30, 2022 -1.45 Mn
Mar 31, 2022 42.53 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 -45.12 Mn
Jun 30, 2021 -6.64 Mn
Mar 31, 2021 -5.23 Mn
Dec 31, 2020 -3.78 Mn